Biggest News Aggregation in the World
๐Ÿ“ฐ Outcome Sciences News

Page 2 - Outcome Sciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Outcome Sciences. Real-time updates on events, politics, business and more.

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.
United States David Goldfarb Biontech Comirnaty Tracy Kirkham Tim Evans Emily Henderson

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

We must harness digital technology for 21st-century health care

We must harness digital technology for 21st-century health care By Karimah Es Sabar. Published on Apr 8, 2021 4:16pm While digital health such as telemedicine doesnโ€™t replace the value of face-to-face contact, disruptive technologies such as real-time, embedded monitoring tools will help health-care specialists track and monitor patients without needing to see them. The federal governments COVID-19 Exposure Notification app for smartphones (Health Canada) โ€œHiding within those mou...
British Columbia Atul Butte Public Health Data Portal Industry Strategy Council Dermatology Intelligent Network Centre For Health Evaluation Outcome Sciences

NeonMind Biosciences Inc: NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

NeonMind Biosciences Inc: NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity NeonMind Biosciences Inc. (CSE: NEON) (" NeonMind"), a psychedelic drug development company, is pleased to announce that it has engaged Dr. C. Laird Birmingham to consult with NeonMind to develop protocols for its Phase 2 Clinical Trial administering psilocybin to treat obese patients. Dr. Birmingham is a Specialist in Internal Medicine, an Epidemi...
United Kingdom British Columbia C Laird Birmingham Member Of The Brain Research Centre Exvera Communications Inc Centre For Health Evaluation

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science